Recently Featured

UAE Approves AstraZeneca’s Baxfendy for Hypertension

May 23, 2026
AstraZeneca has received approval from the Emirates Drug Evaluation (EDE) in the UAE for Baxfendy, a novel treatment employing the active ingredient baxdrostat, aimed at addressing uncontrolled hypertension. This approval marks a significant milestone for AstraZeneca as it expands its portfolio in the cardiovascular space, reflecting the growing demand for innovative therapies to manage hypertension…

AAVs in Focus: Practical Approaches to Capsid Analytics and Plasmid DNA Control

May 22, 2026
Adeno-associated viruses (AAVs) are solidifying their role as a cornerstone of gene therapy, driven by innovations in vector design and manufacturing practices. A recent three-part webinar series hosted by the United States Pharmacopeia (USP) delves into the current AAV landscape, offering insights into capsid characterization and the critical role of plasmid DNA as a starting…

CDER Approves New Molecular Entities and Biologics from 1985 to 2019

May 22, 2026
The Center for Drug Evaluation and Research (CDER) has compiled a comprehensive dataset detailing all New Molecular Entities (NMEs) and new biological products approved between 1985 and 2019. This compilation includes both small molecule drugs sanctioned under New Drug Applications (NDAs) and novel biologics, providing a crucial resource for industry stakeholders. This extensive listing not…

Males Who Discuss Suicide Seek Help Less Often Than Females, Report Finds

May 22, 2026
Despite the alarming statistics surrounding suicide, a recent report from Crisis Text Line reveals a significant disparity in help-seeking behaviors between genders. While women are three times more likely to report suicidal thoughts and attempts, men account for nearly 80% of suicide fatalities in the U.S. This stark contrast highlights a critical issue: men are…

Ongoing Cases